baxter travenol laboratori said it hyland therapeut unit has start first human clinic trial genet engin factor viii clot agent miss from blood most hemophiliac said unlik factor viii concentr current genet engin factor viii would not limit avail human plasma and will complet free from blood born virus includ aid and all form hepat baxter said baxter also said final state clinic trial high purifi form factor viii deriv from human plasma produc use advanc process incorpor monoclon antibodi purif said genet institut public held biotechnolog compani which baxter sharehold will suppli protein use for human clinic test well substanti portion ongo product requir reuter 